HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Some pharmacological properties and cumulative, subchronic and chronic toxicity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)] -1,2,3,4-tetrahydro-beta-carbolin-1-one (B-193).

Abstract
The cumulative, subchronic and chronic toxicity of B-193 were studied on the rats and mice. It was found that this compound exerted weak tendency to cumulation in the body. Only the highest doses of B-193 (70, 40 mg/kg po for 12 weeks) caused the increase of animals mortality. Studies on subchronic and chronic toxicity have demonstrated, that B-193 administrated po or ip for 3 weeks, and po for 12 weeks, in general, neither affects the body weight gain nor the mass and morphology of heart, liver and kidneys, as well as spontaneous locomotor activity of animals. The weak depressant effect of B-193 on peripheral blood morphology was seen only after 3 weeks po or ip treatment with this compound. The moderate effect of B-193 on activity of alanine and aspartate transaminases (A1At and AspAt) and serum protein level found after 3 weeks of treatment, was no longer observed after 12 weeks of treatment. This could indicate that above effects of B-193 are reversible.
AuthorsM Sieklucka-Dziuba, G Rajtar, Z Kleinrok
JournalPolish journal of pharmacology (Pol J Pharmacol) 1995 Jul-Aug Vol. 47 Issue 4 Pg. 305-11 ISSN: 1230-6002 [Print] Poland
PMID8616509 (Publication Type: Journal Article)
Chemical References
  • Carbolines
  • Piperazines
  • Serotonin Antagonists
  • B 193
Topics
  • Animals
  • Body Weight (drug effects)
  • Carbolines (toxicity)
  • Dose-Response Relationship, Drug
  • Male
  • Mice
  • Mice, Inbred Strains
  • Piperazines (toxicity)
  • Rats
  • Rats, Wistar
  • Serotonin Antagonists (toxicity)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: